Ipsen S.A.:企業の戦略・SWOT・財務情報

◆英語タイトル:Ipsen S.A. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1940
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Ipsen S.A. – Strategy, SWOT and Corporate Finance Report
Summary

Ipsen S.A. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Ipsen S.A. (Ipsen or ‘the company’) is a global biopharmaceutical company that offers drugs on targeted therapeutic areas such as oncology, endocrinology, neurology, and primary care. The company offers products to treat gastrointestinal disorders, neurodegenerative pathologies and rheumatology diseases. It sells its drugs through distributors directly to public hospitals. Ipsen sells its products under brands such as Adrovance, Adenuric, Decapeptyl, Dysport, NutropinAq, Smecta, Somatuline and Tanakan. Ipsen operates research facilities in Paris-Saclay, France; Cambridge, the US; and Oxford, the UK. Ipsen primarily operates in Europe, North America, Asia and rest of the world. Ipsen is headquartered in Boulogne-Billancourt, Paris France.

Scope

- Detailed information on Ipsen S.A. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Ipsen S.A. in the form of a SWOT analysis
- An in-depth view of the business model of Ipsen S.A. including a breakdown and examination of key business segments
- Intelligence on Ipsen S.A.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Ipsen S.A., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Ipsen S.A. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Ipsen S.A. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Ipsen S.A.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Ipsen S.A.: Company Overview 9
Ipsen S.A.: Overview and Key Facts 9
Ipsen S.A.: Overview 9
Ipsen S.A.: Key Facts 9
Ipsen S.A.: Key Employees 10
Ipsen S.A.: Key Employee Biographies 12
Ipsen S.A.: Major Products and Services 15
Ipsen S.A.: Company History 16
Ipsen S.A.: Management Statement 22
Ipsen S.A.: Locations and Subsidiaries 24
Ipsen S.A.: Key Competitors 25
Ipsen S.A.: Company Analysis 26
Ipsen S.A.: Business Description 26
Ipsen S.A.: SWOT Analysis 27
Ipsen S.A.: SWOT Overview 27
Ipsen S.A.: Strengths 27
Ipsen S.A.: Weaknesses 28
Ipsen S.A.: Opportunities 28
Ipsen S.A.: Threats 29
Ipsen S.A.: Corporate Financial Deals Activity 31
Ipsen S.A.: Financial Deals Overview 31
Ipsen S.A.: Targets and Partners 33
Ipsen S.A.: Top Deals 2014 – 2018YTD* 34
Ipsen S.A.: Advisors 35
Ipsen S.A.: Top Legal Advisors 35
Ipsen S.A.: Mergers and Acquisitions 36
Ipsen S.A.: Corporate Venturing 37
Ipsen S.A.: Capital Raising 38
Ipsen S.A.: Partnership 39
Ipsen S.A.: Recent Developments 40
Ipsen S.A.: News and Events Summary 40
Ipsen S.A.: Business Expansion 43
Ipsen S.A.: Contracts 44
Ipsen S.A.: Corporate Governance 44
Ipsen S.A.: Financial Performance 45
Ipsen S.A.: Market Developments 46
Ipsen S.A.: Strategy and Operations 47
Appendix 49
Contact Us 49
Methodology 49
About MarketLine 50

List of Tables
Table 1: Ipsen S.A.: Key Facts
Table 2: Ipsen S.A.: Key Employees
Table 3: Ipsen S.A.: Locations and Subsidiaries
Table 4: Ipsen S.A.: Key Competitors
Table 5: Ipsen S.A.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Ipsen S.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Ipsen S.A.: M&A Average Deal Size - Value (US$m)
Table 8: Ipsen S.A.: Targets and Partners
Table 9: Ipsen S.A.: Top Deals 2014 - 2018YTD*
Table 10: Ipsen S.A.: Legal Advisor Ranking by Value (US$m)
Table 11: Ipsen S.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Ipsen S.A.: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Ipsen S.A.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 14: Ipsen S.A.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 15: Ipsen S.A.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 16: Ipsen S.A.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 17: Ipsen S.A.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 18: Ipsen S.A.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 19: Ipsen S.A.: News and Events Summary
Table 20: Ipsen S.A.: Business Expansion
Table 21: Ipsen S.A.: Contracts
Table 22: Ipsen S.A.: Corporate Governance
Table 23: Ipsen S.A.: Financial Performance
Table 24: Ipsen S.A.: Market Developments
Table 25: Ipsen S.A.: Strategy and Operations

List of Figures
Figure 1: Ipsen S.A.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Ipsen S.A.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Ipsen S.A.: M&A Average Deal Size - Value (US$m)
Figure 4: Ipsen S.A.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Ipsen S.A.: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Ipsen S.A.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 7: Ipsen S.A.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 8: Ipsen S.A.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 9: Ipsen S.A.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 10: Ipsen S.A.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 11: Ipsen S.A.: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Ipsen S.A.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lepu Medical Technology (Beijing) Co Ltd (300003)-製薬・医療分野:企業M&A・提携分析
    Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical device company that designs, develops, and distributes medical equipments. The company’s products include interventional cardiology products, cardiac in vitro diagnosis products, occlusion devices, pacemaker, angiographic e …
  • PT Sun Life Financial Indonesia:企業の戦略・SWOT・財務情報
    PT Sun Life Financial Indonesia - Strategy, SWOT and Corporate Finance Report Summary PT Sun Life Financial Indonesia - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Taiga Building Products Ltd (TBL):企業の財務・戦略的SWOT分析
    Taiga Building Products Ltd (TBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Albireo Pharma Inc (ALBO)-製薬・医療分野:企業M&A・提携分析
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., is a specialty biopharmaceutical company that focuses on the development and commercialization of innovative bile acid modulators for the treatment of orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and d …
  • ABITEC Corp:企業の戦略的SWOT分析
    ABITEC Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • New Zealand Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary New Zealand Pharmaceuticals Ltd (NZP) a subsidiary of Archer Capital, manufactures and supplies pharmaceutical intermediates and diagnostic products for pharmaceutical and microbiological media companies. It also offers biochemicals and natural extracts for health, cosmetic, biotechnology, f …
  • Caixa Economica Federal:企業の戦略・SWOT・財務情報
    Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report Summary Caixa Economica Federal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Nobel Biocare Services AG:企業の戦略的SWOT分析
    Nobel Biocare Services AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Regis Corporation (RGS):企業の財務・戦略的SWOT分析
    Regis Corporation (RGS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • eGain Corp (EGAN):企業の財務・戦略的SWOT分析
    Summary eGain Corp (eGain) is a technology company that provides cloud-based and on-site customer engagement software solutions. The company offers products such as eGain case manager, eGain chat, eGain clicktocall, eGain cobrowse, eGain community, eGain consulting, and eGain virtual assistant. It a …
  • PPC Limited:企業の戦略・SWOT・財務情報
    PPC Limited - Strategy, SWOT and Corporate Finance Report Summary PPC Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • CRISPR Therapeutics:戦略・SWOT・企業財務分析
    CRISPR Therapeutics - Strategy, SWOT and Corporate Finance Report Summary CRISPR Therapeutics - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Ergon, Inc.:石油・ガス:M&Aディール及び事業提携情報
    Summary Ergon Inc (Ergon) is an integrated energy company that carries out the exploration and production of crude oil and natural gas, processing, transportation and terminaling of crude oil, storage, marketing and distribution of specialty petroleum products. The company also manufactures and mark …
  • Naftna industrija Srbije ad (NIIS):電力:M&Aディール及び事業提携情報
    Summary Naftna industrija Srbije ad (NIS), a subsidiary of Gazprom Neft, is an integrated energy company that conducts oil and gas exploration, production and refining, and sales and distribution of a broad range of petroleum products. Its refined products include motor fuel, diesel fuel, heating oi …
  • Aeon Co., Ltd.:企業の戦略・SWOT・財務分析
    Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aeon Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Allot Ltd (ALLT):企業の財務・戦略的SWOT分析
    Allot Ltd (ALLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Enzymatica AB (ENZY):企業の財務・戦略的SWOT分析
    Summary Enzymatica AB (Enzymatica) is a life science company that develops and markets medical products for various virus and bacterial infections. The company offers mouth sprays and veterinary products. Its veterinary products comprise dental health and skin relief enzyme based gels, dental and de …
  • Cenovus Energy Inc (CVE):石油・ガス:M&Aディール及び事業提携情報
    Summary Cenovus Energy Inc (Cenovus Energy) is an integrated energy company, which explores, develops, produces and markets crude oil, natural gas liquids (NGLs) and natural gas. Cenovus Energy produces natural gas and oil through conventional and oil sands reserves in Athabasca region of northeaste …
  • Huron Consulting Group Inc:企業の戦略・SWOT・財務分析
    Huron Consulting Group Inc - Strategy, SWOT and Corporate Finance Report Summary Huron Consulting Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Penn United Technologies, Inc.:企業の戦略・SWOT・財務情報
    Penn United Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary Penn United Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆